Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis [0.03%]
Mohammed Abdulgayoom,Mohammad S Afana,Leen Haj Saleh et al.
Mohammed Abdulgayoom et al.
Chronic myelomonocytic leukemia (CMML) is a biologically heterogeneous myelodysplastic/myeloproliferative neoplasm with limited disease-modifying options beyond hypomethylating agents (HMAs) and allogeneic hematopoietic stem cell transplant...
A Case Report of Tyrosine Kinase Inhibitor Interruption in a Patient with Multilineage Philadelphia Positive Acute Lymphoblastic Leukemia [0.03%]
慢性髓性白血病-急性淋巴细胞白血病变异型靶向治疗1例报告
Hannah Goulart,Julie Braish,Nicholas J Short et al.
Hannah Goulart et al.
Introduction: Measurable residual disease (MRD) assessment in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) commonly relies on RT-PCR detection of BCR::ABL1 transcripts. However, discordance betw...
Case Reports
Acta haematologica. 2026 Mar 31:1-8. DOI:10.1159/000551699 2026
A Complex Case of Anti-e Mimicking Autoantibody Development Leading to Warm Autoimmune Hemolytic Anemia: Case Report [0.03%]
一种导致温免疫性溶血性贫血的抗-i模仿自身抗体复杂病例：案例报告
Ilsa Hale,Kristina L Kunes,Jean Sabile et al.
Ilsa Hale et al.
Introduction: Newly diagnosed autoimmune hemolytic anemia (AIHA) develops in 1-3 individuals per 100,000 people per year. Warm autoimmune hemolytic anemia (WAIHA) is the most common type of AIHA, accounting for approximat...
Case Reports
Acta haematologica. 2026 Mar 13:1-11. DOI:10.1159/000550486 2026
Maria Frost,Vivek Subbiah,Branko Cuglievan et al.
Maria Frost et al.
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Pregnancy-Associated Aplastic Anemia [0.03%]
allo-HSCT治疗妊娠相关再生障碍性贫血患者的预后研究
Xinxin Li,Liangliang Wu,Yumiao Li et al.
Xinxin Li et al.
The prognosis and management of pregnancy-associated aplastic anemia (PAA) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) remain uncertain. This study evaluated the safety and feasibility of allo-HSCT in 18 patient...
Chronic Myeloid Leukemia (CML): historical perspective, pathophysiology, and treatment advances [0.03%]
慢性粒细胞白血病（CML）：历史回顾、病理生理和治疗进展
Songphol Tungjitviboonkun,Lea Daran,Sorrawit Unsuwan
Songphol Tungjitviboonkun
Chronic myeloid leukemia (CML) was the first leukemia to be described in medical literature and remains one of the most well-studied hematologic malignancies. This review traces the historical evolution of CML research, from its first clini...
Differentiation Therapy in Acute Myeloid Leukemia: Advances in Phenotypic Screening and CRISPR-based Functional Genomics [0.03%]
急性髓系白血病的分化治疗：表型筛选和CRISPR功能基因组学研究的新进展
Shinichiro Takahashi
Shinichiro Takahashi
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous malignancy marked by a differentiation block in myeloid progenitors. Despite advances in molecular-targeted therapies, long-term outcomes remain poor, underscoring t...
BEAC induction regimen and prior thoracic radiotherapy increases the risk of ASCT associated pneumonitis [0.03%]
BEAC诱导方案及既往胸部放疗增加ASCT相关肺炎的风险
Elina Kaprio,Anna Jokimäki,Hanne Kuitunen et al.
Elina Kaprio et al.
High-dose chemotherapy (HDT) followed by autologous stem cell transplant (ASCT) has been standard of care in the treatment of relapsed and refractory lymphoma. Some severe toxicities are associated with this treatment modality. Pulmonary to...
Impact of COVID-19 pandemic on progression free survival estimates in oncology: the role of non-informative censoring [0.03%]
新冠肺炎疫情对肿瘤学无进展生存率估计的影响：非信息删失的作用
Vadim Lesan,Cristian Munteanu
Vadim Lesan
Effectiveness of integrative medicine in the management of lymphoma survivors: an exploratory preference-based controlled trial [0.03%]
淋巴瘤患者康复中整合医学疗效的探索性偏爱控制试验
Ilana Levy Yurkovski,Samuel Attias,Elad Schiff et al.
Ilana Levy Yurkovski et al.
Background: Lymphoma has recovery rates above 60%, but many survivors experience impaired quality-of-life (QoL) requiring survivorship care. This study evaluated the role of an integrative oncology (IO) clinic in managing...